| 9bax |
PI4KA complex bound to C-terminus of EFR3A |
76.6 |
262.5 |
ELECTRON MICROSCOPY |
GOOD
|
| 9baz |
CryoEM structure of DIM2-HP1 complex |
34.8 |
124.2 |
ELECTRON MICROSCOPY |
GOOD
|
| 9bb0 |
D-Dopachrome Tautomerase with 4-Hydroxyphenylpyruvate Bound in Catalytic Site at Atomic (0.98 Angstrom) Resolution |
24.4 |
74.6 |
X-RAY DIFFRACTION |
EXCELLENT
|
| 9bb1 |
Backbone Modification in the GA Module of Protein PAB: Wild-type Sequence |
10.1 |
33.5 |
SOLUTION NMR |
REASONABLE
|
| 9bb2 |
Backbone Modification in the GA Module of Protein PAB: beta3-residues at positions 20 and 24 |
10.1 |
33.8 |
SOLUTION NMR |
REASONABLE
|
| 9bb3 |
Backbone Modification in the GA Module of Protein PAB: beta3-residues at positions 22 and 26 |
10.2 |
34.6 |
SOLUTION NMR |
REASONABLE
|
| 9bb4 |
Backbone Modification in the GA Module of Protein PAB: beta3-residues at positions 23 and 26 |
10.4 |
35.4 |
SOLUTION NMR |
REASONABLE
|
| 9bb5 |
Backbone Modification in the GA Module of Protein PAB: ACPC residues at positions 22 and 26 |
10.1 |
39.8 |
SOLUTION NMR |
REASONABLE
|
| 9bb6 |
Backbone Modification in the GA Module of Protein PAB: ACPC residues at positions 5 and 13, beta3 residue at position 9 |
10.1 |
33.7 |
SOLUTION NMR |
REASONABLE
|
| 9bb7 |
Backbone Modification in the GA Module of Protein PAB: ACPC residues at positions 5 and 39, beta3 residue at position 26 |
10.3 |
35.5 |
SOLUTION NMR |
REASONABLE
|
| 9bb8 |
Crystal structure of human alpha parvalbumin |
14.3 |
46.5 |
X-RAY DIFFRACTION |
GOOD
|
| 9bb9 |
Structure of S1_8A, a lambda-carrageenan specific sulfatase |
35.2 |
115.2 |
X-RAY DIFFRACTION |
GOOD
|
| 9bba |
Structure of S1_8C, a lambda-carrageenan specific sulfatase |
52.7 |
185.6 |
X-RAY DIFFRACTION |
GOOD
|
| 9bbb |
Human CYP3A4 bound to an inhibitor |
23.2 |
71.2 |
X-RAY DIFFRACTION |
EXCELLENT
|
| 9bbc |
TCR GDN detergent micelle |
35.4 |
123.0 |
ELECTRON MICROSCOPY |
GOOD
|
| 9bbd |
Structure of S1_8B, a lambda-carrageenan specific sulfatase |
31.0 |
102.4 |
X-RAY DIFFRACTION |
GOOD
|
| 9bbe |
Co-crystal structure of human DDB1 bound to fragment UB028668 |
— |
— |
X-RAY DIFFRACTION |
—
|
| 9bbf |
Structure of Clostridioides difficile Component A (50-463) in Complex with a CDTb Oligomer |
41.1 |
122.3 |
ELECTRON MICROSCOPY |
REASONABLE
|
| 9bbg |
Co-crystal structure of human DDB1 bound to fragment UB028671 |
— |
— |
X-RAY DIFFRACTION |
—
|
| 9bbh |
Co-crystal structure of human DDB1 bound to fragment UB028670 |
— |
— |
X-RAY DIFFRACTION |
—
|
| 9bbi |
Co-crystal structure of human DDB1 bound to fragment UB028669 |
— |
— |
X-RAY DIFFRACTION |
—
|
| 9bbj |
M. tuberculosis ClpC1-NTD complexed with a click chemistry analog of Rufomycin |
15.6 |
53.6 |
X-RAY DIFFRACTION |
GOOD
|
| 9bbk |
SARS-CoV-2 full-length spike protein with His1271Lys substitution in the coatomer binding motif, 2RBD-up conformation (SPIKE-KxK) |
52.3 |
174.6 |
ELECTRON MICROSCOPY |
GOOD
|
| 9bbl |
THF filament generated from 4E-Tau(297-407) under neutral Mg2+ condition |
42.7 |
133.3 |
ELECTRON MICROSCOPY |
REASONABLE
|
| 9bbm |
PHF filament generated from 4E-Tau(297-407) under neutral Mg2+ condition |
34.1 |
131.1 |
ELECTRON MICROSCOPY |
REASONABLE
|
| 9bbn |
Cryo-EM structure of Chikungunya virus asymmetric unit with Fab C9 |
70.6 |
251.0 |
ELECTRON MICROSCOPY |
GOOD
|
| 9bbo |
Proline utilization A complexed with the product L-glutamate in the aldehyde dehydrogenase active site |
40.9 |
123.7 |
X-RAY DIFFRACTION |
GOOD
|
| 9bbp |
SARS-CoV-2 Mpro in complex with compound 12d inhibitor |
22.5 |
78.2 |
X-RAY DIFFRACTION |
GOOD
|
| 9bbq |
SARS-CoV-2 Mpro in complex with compound 6c inhibitor |
22.1 |
75.8 |
X-RAY DIFFRACTION |
GOOD
|
| 9bbr |
SARS-CoV-2 Mpro in complex with compound 6b inhibitor |
22.4 |
83.7 |
X-RAY DIFFRACTION |
REASONABLE
|
| 9bbs |
SARS-CoV-2 Mpro in complex with compound 6d inhibitor |
22.3 |
81.1 |
X-RAY DIFFRACTION |
GOOD
|
| 9bbt |
SARS-CoV-2 Mpro in complex with compound 6f inhibitor |
22.1 |
74.6 |
X-RAY DIFFRACTION |
GOOD
|
| 9bbu |
SARS-CoV-2 Mpro in complex with compound 6h inhibitor |
26.5 |
83.4 |
X-RAY DIFFRACTION |
EXCELLENT
|
| 9bbv |
SARS-CoV-2 Mpro in complex with compound 6j inhibitor |
22.5 |
84.7 |
X-RAY DIFFRACTION |
REASONABLE
|
| 9bbw |
SARS-CoV-2 Mpro in complex with compound 6k inhibitor |
22.4 |
75.2 |
X-RAY DIFFRACTION |
GOOD
|
| 9bbx |
SARS-CoV-2 Mpro in complex with compound 6l inhibitor |
22.2 |
75.4 |
X-RAY DIFFRACTION |
GOOD
|
| 9bby |
SARS-CoV-2 Mpro in complex with compound 18b inhibitor |
22.4 |
79.6 |
X-RAY DIFFRACTION |
GOOD
|
| 9bbz |
SARS-CoV-2 Mpro in complex with compound 18d inhibitor |
26.5 |
82.2 |
X-RAY DIFFRACTION |
EXCELLENT
|
| 9bc0 |
SARS-CoV-2 Mpro in complex with compound 18r inhibitor |
22.2 |
74.1 |
X-RAY DIFFRACTION |
GOOD
|
| 9bc1 |
SARS-CoV-2 Mpro in complex with peptide mimetic inhibitor |
27.1 |
83.1 |
X-RAY DIFFRACTION |
GOOD
|
| 9bc2 |
Transglutaminase 2 - Open State |
37.6 |
102.5 |
X-RAY DIFFRACTION |
REASONABLE
|
| 9bc3 |
Transglutaminase 2 - Alternate state |
34.6 |
130.4 |
X-RAY DIFFRACTION |
GOOD
|
| 9bc4 |
Transglutaminase 2 - Intermediate State |
25.8 |
103.5 |
X-RAY DIFFRACTION |
REASONABLE
|
| 9bc5 |
AAV-2 Rep68-AAVS1 heptameric complex |
53.2 |
151.4 |
ELECTRON MICROSCOPY |
GOOD
|
| 9bc6 |
HCN1 M305L with propofol |
40.2 |
123.4 |
ELECTRON MICROSCOPY |
GOOD
|
| 9bc7 |
HCN1 M305L holo |
41.9 |
129.9 |
ELECTRON MICROSCOPY |
GOOD
|
| 9bc8 |
Cargo-loaded Myxococcus xanthus EncA encapsulin engineered pore mutant with T=4 icosahedral symmetry |
42.9 |
159.1 |
ELECTRON MICROSCOPY |
GOOD
|
| 9bc9 |
Structure of KLHDC2 bound to SJ10278 |
29.5 |
97.5 |
X-RAY DIFFRACTION |
GOOD
|
| 9bca |
Structure of KLHDC2 bound to SJ46411 |
29.5 |
97.6 |
X-RAY DIFFRACTION |
GOOD
|
| 9bcb |
Crystal structure of human cellular retinol binding protein 3 in complex with C11 TopFluor MG |
23.3 |
72.6 |
X-RAY DIFFRACTION |
GOOD
|